80 related articles for article (PubMed ID: 12478906)
41. Reversal of multidrug resistance by gefitinib via RAF1/ERK pathway in pancreatic cancer cell line.
Xiao Z; Ding N; Xiao G; Wang S; Wu Y; Tang L
Anat Rec (Hoboken); 2012 Dec; 295(12):2122-8. PubMed ID: 22907845
[TBL] [Abstract][Full Text] [Related]
42. [Correlation of cyclooxygenase-2 expression to P-glycoprotein expression in B-cell non-Hodgkin's lymphoma].
Li B; Zhong MZ; Tang TF; Liu W; Huang J
Ai Zheng; 2007 Aug; 26(8):851-5. PubMed ID: 17697546
[TBL] [Abstract][Full Text] [Related]
43. Epigenetic regulation of the ABCB1 gene in drug-sensitive and drug-resistant lymphoid tumour cell lines obtained from canine patients.
Tomiyasu H; Goto-Koshino Y; Fujino Y; Ohno K; Tsujimoto H
Vet J; 2014 Jan; 199(1):103-9. PubMed ID: 24332606
[TBL] [Abstract][Full Text] [Related]
44. ABCB1 gene polymorphisms are not associated with treatment outcome in elderly acute myeloid leukemia patients.
van der Holt B; Van den Heuvel-Eibrink MM; Van Schaik RH; van der Heiden IP; Wiemer EA; Vossebeld PJ; Löwenberg B; Sonneveld P
Clin Pharmacol Ther; 2006 Nov; 80(5):427-39. PubMed ID: 17112800
[TBL] [Abstract][Full Text] [Related]
45. Reversal effect of Raf-1/Mdr-1 siRNAs co-transfection on multidrug resistance in KBv200 cell line.
Dong Y; Shao S; Hu J; Yang P
Oral Oncol; 2009 Nov; 45(11):991-7. PubMed ID: 19631573
[TBL] [Abstract][Full Text] [Related]
46. [Mechanisms of multidrug resistance in tumor cells and analytical methods for its detection].
Takemura Y; Kobayashi H; Miyachi H
Rinsho Byori; 1998 Aug; 46(8):745-58. PubMed ID: 9760826
[TBL] [Abstract][Full Text] [Related]
47. Expression of P-glycoprotein and glutathione-S-transferase in recurrent lymphomas: the possible role of Epstein-Barr virus, immunophenotypes, and other predisposing factors.
Cheng AL; Su IJ; Chen YC; Lee TC; Wang CH
J Clin Oncol; 1993 Jan; 11(1):109-15. PubMed ID: 8093366
[TBL] [Abstract][Full Text] [Related]
48. Expression levels of human P-glycoprotein in in vitro cell lines: correlation between mRNA and protein levels for P-glycoprotein expressed in cells.
Shirasaka Y; Konishi R; Funami N; Kadowaki Y; Nagai Y; Sakaeda T; Yamashita S
Biopharm Drug Dispos; 2009 Apr; 30(3):149-52. PubMed ID: 19243013
[TBL] [Abstract][Full Text] [Related]
49. [Effect of hypoxia on the chemotherapeutic sensitivity of human ovarian cancer cells to paclitaxel and its mechanism].
Huang L; Zhang QH; Ao QL; Xing H; Lu YP; Ma D
Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):96-100. PubMed ID: 17645840
[TBL] [Abstract][Full Text] [Related]
50. The prognostic significance of the expression and function of multidrug resistance transporter proteins in acute myeloid leukemia: studies of the Southwest Oncology Group Leukemia Research Program.
Willman CL
Semin Hematol; 1997 Oct; 34(4 Suppl 5):25-33. PubMed ID: 9408958
[TBL] [Abstract][Full Text] [Related]
51. [Significance of functional assay of multidrug resistance for prediction of chemotherapy outcomes in acute leukemia].
Ye X; Tan H; Feng Y; Su H; Lai YY; Pang Y
Ai Zheng; 2003 Aug; 22(8):856-60. PubMed ID: 12917035
[TBL] [Abstract][Full Text] [Related]
52. [Inhibition of multidrug resistance related P-gp expression in human neuroblastoma by antisense peptide nucleic acid].
Guo H; Zhang QL; Zhang J; Wang CW; Kong JX; Liu FS; Ma DX; Bian JF
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Jun; 27(3):300-4. PubMed ID: 16038264
[TBL] [Abstract][Full Text] [Related]
53. The novel Akt inhibitor, perifosine, induces caspase-dependent apoptosis and downregulates P-glycoprotein expression in multidrug-resistant human T-acute leukemia cells by a JNK-dependent mechanism.
Chiarini F; Del Sole M; Mongiorgi S; Gaboardi GC; Cappellini A; Mantovani I; Follo MY; McCubrey JA; Martelli AM
Leukemia; 2008 Jun; 22(6):1106-16. PubMed ID: 18385752
[TBL] [Abstract][Full Text] [Related]
54. Overexpression of SORCIN is a Prognostic Biomarker for Multidrug-Resistant Pediatric Acute Lymphoblastic Leukemia and Correlates with Upregulated MDR1/P-gp.
Dabaghi M; Rahgozar S; Moshtaghian J; Moafi A; Abedi M; Pourabutaleb E
Genet Test Mol Biomarkers; 2016 Sep; 20(9):516-21. PubMed ID: 27382961
[TBL] [Abstract][Full Text] [Related]
55. Controlled trial of dexverapamil, a modulator of multidrug resistance, in lymphomas refractory to EPOCH chemotherapy.
Wilson WH; Bates SE; Fojo A; Bryant G; Zhan Z; Regis J; Wittes RE; Jaffe ES; Steinberg SM; Herdt J
J Clin Oncol; 1995 Aug; 13(8):1995-2004. PubMed ID: 7636540
[TBL] [Abstract][Full Text] [Related]
56. A novel podophyllotoxin derivative (YB-1EPN) induces apoptosis and down-regulates express of P-glycoprotein in multidrug resistance cell line KBV200.
Chen H; Bi W; Cao B; Yang Z; Chen S; Shang H; Yu P; Yang J
Eur J Pharmacol; 2010 Feb; 627(1-3):69-74. PubMed ID: 19879873
[TBL] [Abstract][Full Text] [Related]
57. Reversal of multidrug resistance by small interfering RNA (siRNA) in doxorubicin-resistant MCF-7 breast cancer cells.
Dönmez Y; Gündüz U
Biomed Pharmacother; 2011 Mar; 65(2):85-9. PubMed ID: 21237614
[TBL] [Abstract][Full Text] [Related]
58. Expression of mdr-1 in refractory lymphoma: quantitation by polymerase chain reaction and validation of the assay.
Kang YK; Zhan Z; Regis J; Alvarez M; Robey R; Meadows B; Dickstein B; Lee JS; Otsuki T; Stetler-Stevenson M
Blood; 1995 Aug; 86(4):1515-24. PubMed ID: 7632959
[TBL] [Abstract][Full Text] [Related]
59. Relationship between mdr-1 messenger-RNA expression and anticancer drug-sensitivity in human hepatocellular-carcinoma cell-lines.
Sasaki F; Ishimura H; Hata Y; Uchino J
Oncol Rep; 1995 Mar; 2(2):309-12. PubMed ID: 21597733
[TBL] [Abstract][Full Text] [Related]
60. Genetic polymorphism in MDR-1: a tool for examining allelic expression in normal cells, unselected and drug-selected cell lines, and human tumors.
Mickley LA; Lee JS; Weng Z; Zhan Z; Alvarez M; Wilson W; Bates SE; Fojo T
Blood; 1998 Mar; 91(5):1749-56. PubMed ID: 9473242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
